Patient-reported 'ever had' and 'current' long-term physical symptoms after prostate cancer treatments

BJU International

Volumn 116, Issue 3, 2015, Pages 397-406

  Gavin, Anna T ^a   Drummond, Frances J ^b   Donnelly, Conan ^a   O'Leary, Eamonn ^b   Sharp, Linda ^c   Kinnear, Heather R ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

patient reported outcomes; population; prostate cancer

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; BREAST DISEASE; CANCER REGISTRY; CANCER SURVIVOR; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROPATHY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FOLLOW UP; HEALTH SURVEY; HORMONAL THERAPY; HOT FLUSH; HUMAN; INFANT; IRELAND; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; SELF REPORT; SYMPTOMATOLOGY; TUMOR VOLUME; UNITED KINGDOM; URINE INCONTINENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; HUMANS; IRELAND; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 84938991281     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13036     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v 1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://globocan.iarc.fr. Accessed January 2014
2. Maddams J, Utley M, Moller H,. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012; 107: 1195-202
3. Bray F, Lortet Tieulent J, Ferlay J, Forman D, Auvinen A,. Cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2012; 46: 3040-52
4. Donnelly D,. Living with and Beyond Cancer. A Report on Cancer Prevalence in Northern Ireland 2010. Northern Ireland Cancer Registry, 2013. Available at: http://www.qub.ac.uk/research-centres/nicr/FileStore/PDF/Incidence/Filetoupload,382846,en.pdf. Accessed February 2014
5. Gomella LG, Johannes J, Trabulsi EJ,. Current Prostate cancer treatments: effect on quality of life. Urology 2009; 73: 28-35
6. National Institute of Health and Care Excellence 2014. Prostate Cancer: Diagnosis and Treatment. Update of Clinical Guidelines 58 (Clinical Guideline 175). Available at: http://www.nice.org.uk/CG175. Accessed March 2014
7. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome amongst prostate cancer survivors. N Engl J Med 2008; 358: 1250-61
8. Litwin MS, Sadetsky N, Pasta DJ, Lubeck DP,. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J Urol 2004; 172: 515-9
9. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004; 96: 1358-67
10. Kazer MW, Psutka SP, Latini DW, Bailey DE Jr,. Psychosocial aspects of active surveillance. Curr Opin Urol 2013; 23: 273-7
11. Wallerstedt A, Carlssen S, Steineck G, et al. Patient and tumour-related factors for prediction of urinary incontinence after radical prostatectomy. Scand J Urol 2013; 47: 272-81
12. Budaus L, Bolla M, Bossi A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 2012; 61: 112-27
13. O'Shaughnessy PK, Ireland C, Pelentsov L, Thomas LA, Esterman AJ,. Impaired sexual function and prostate cancer: a mixed method investigation into the experiences of men and their partners. J Clin Nurs 2013; 22: 3492-502
14. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76
15. van Andel G, Bottomley A, Fosså SD, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008; 44: 2418-24
16. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
17. Lovibond SH, Lovibond PF,. Manual for the Depression Anxiety Stress Scales, 2nd edn, Sydney: Psychology Foundation, 1995
18. O'Connor AM,. User Manual-Decision Regret Scale. Ottawa: Ottawa Hospital Research Institute, 1996. Available at: http://decisionaid.ohri.ca/docs/develop/User-Manuals/UM-Regret-Scale.pdf. Accessed March 2015
19. Clopper C, Pearson ES,. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26: 404-13
20. Glaser AW, Fraser LK, Corner J, et al. Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey. BMJ Open 2013; 3: e002317
21. Department of Health, 2010. RTDS Annual Report 2009/2010. Available at: http://www.gov.uk/government/uploads/system/uploads/attachment-data/file/215528/dh-128868.pdf. Accessed April 2014
22. Korfage IJ, Essink-Bot ML, Borsboom GJ, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005; 116: 291-6
23. Cuppone F, Bria E, Giannarelli D, et al. Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials. BMC Cancer 2010; 10: 675
24. Bagrodia A, DiBlasio CJ, Wake RW, Derweesh IH,. Adverse effects of androgen deprivation therapy in prostate cancer: current management issues. Indian J Urol 2009; 25: 169-76
25. Dearnaley DP, Khoo V, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999; 353: 267-72
26. Sooriakumaran P, Nyberg T, Akre O, et al. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ 2014; 348: g1502
27. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR,. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002; 14: 422-32
28. Pinnock CB, Stapleton AMF, Marshall VR,. Erectile dysfunction in the community: a prevalence study. Med J Aust 1999; 171: 353-7
29. Chiarelli P, Bower W, Wilson A, Attia J, Sibbritt D,. Estimating the prevalence of urinary and faecal incontinence in Australia: systematic review. Aust J Ageing 2005; 24: 19-27
30. O'Regan CO, Kearney PM, Savva GM, Cronin H, Kenny RA,. Age and sex differences in prevalence and clinical correlates of depression: first results from the Irish Longitudinal Study on Ageing. Int J Geriatr Psychiatry 2013; 28: 1280-7